Company intelligence / Profile preview

Emplicure

Uppsala, Sweden

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Emplicure is a specialty pharmaceutical and consumer health company utilizing a bioceramic platform for drug delivery. Its lead pharmaceutical candidate, EMPLI03 (a tamper-resistant buprenorphine formulation for chronic pain), completed a Phase 1 study but failed to meet its pharmacokinetic target profile. The company subsequently shifted its primary commercial focus toward its Seratek nicotine delivery platform and launched several nicotine pouch brands (KLAR, TECTONIC, and småå) in Sweden and the UK. Emplicure was acquired and delisted from the Nasdaq First North Growth Market in 2023.

Therapeutic areas: PsychiatryNeurology
Modalities: Small molecule
Industry: Biotech

Drug pipeline

2 assets

SERATEK

Unknown

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Emplicure.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emplicure.

Explore the full profile